Free Trial

Labcorp (LH) Competitors

Labcorp logo
$279.40 +4.35 (+1.58%)
Closing price 03:59 PM Eastern
Extended Trading
$279.58 +0.18 (+0.06%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LH vs. HOLX, HSIC, MEDP, AMN, CAH, CHE, DGX, MCK, TMO, and WST

Should you be buying Labcorp stock or one of its competitors? The main competitors of Labcorp include Hologic (HOLX), Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Cardinal Health (CAH), Chemed (CHE), Quest Diagnostics (DGX), McKesson (MCK), Thermo Fisher Scientific (TMO), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector.

Labcorp vs. Its Competitors

Hologic (NASDAQ:HOLX) and Labcorp (NYSE:LH) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Hologic has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

94.7% of Hologic shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 1.9% of Hologic shares are held by insiders. Comparatively, 0.8% of Labcorp shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Labcorp had 1 more articles in the media than Hologic. MarketBeat recorded 14 mentions for Labcorp and 13 mentions for Hologic. Hologic's average media sentiment score of 0.85 beat Labcorp's score of 0.84 indicating that Hologic is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hologic
5 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Labcorp
7 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hologic has a net margin of 13.79% compared to Labcorp's net margin of 5.66%. Hologic's return on equity of 19.69% beat Labcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Hologic13.79% 19.69% 10.82%
Labcorp 5.66%15.45%7.02%

Hologic has higher earnings, but lower revenue than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hologic$4.03B3.74$789.50M$2.4128.10
Labcorp$13.01B1.78$746M$9.0630.84

Hologic presently has a consensus price target of $80.15, suggesting a potential upside of 18.34%. Labcorp has a consensus price target of $292.00, suggesting a potential upside of 4.51%. Given Hologic's higher possible upside, research analysts plainly believe Hologic is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hologic
0 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.61
Labcorp
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.71

Summary

Hologic beats Labcorp on 9 of the 17 factors compared between the two stocks.

Get Labcorp News Delivered to You Automatically

Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LH vs. The Competition

MetricLabcorpMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$23.22B$8.15B$6.10B$21.95B
Dividend Yield1.04%2.81%5.51%3.56%
P/E Ratio30.8473.0985.6829.65
Price / Sales1.7839.21582.4797.91
Price / Cash12.3623.0126.3018.33
Price / Book2.906.8913.244.61
Net Income$746M$247.60M$3.30B$1.01B
7 Day Performance-2.69%1.67%4.67%0.14%
1 Month Performance0.32%1.69%8.40%2.33%
1 Year Performance31.77%11.12%88.01%13.85%

Labcorp Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LH
Labcorp
4.7788 of 5 stars
$279.40
+1.6%
$292.00
+4.5%
+27.4%$23.22B$13.01B30.8470,000
HOLX
Hologic
4.8137 of 5 stars
$67.15
-0.1%
$79.38
+18.2%
-16.1%$14.94B$4.03B27.867,063Analyst Forecast
HSIC
Henry Schein
3.8838 of 5 stars
$66.05
0.0%
$76.67
+16.1%
-6.4%$8.01B$12.67B21.3125,000
MEDP
Medpace
4.2519 of 5 stars
$500.76
+0.8%
$422.27
-15.7%
+54.6%$14.07B$2.11B37.235,900
AMN
AMN Healthcare Services
4.2962 of 5 stars
$18.51
-1.9%
$23.25
+25.6%
-48.3%$709.38M$2.98B-2.382,968Positive News
CAH
Cardinal Health
4.9286 of 5 stars
$154.79
+0.7%
$165.93
+7.2%
+38.6%$36.77B$222.58B24.0057,700Trending News
Analyst Forecast
Analyst Revision
CHE
Chemed
5 of 5 stars
$452.36
-2.1%
$578.50
+27.9%
-25.2%$6.59B$2.43B23.2615,695
DGX
Quest Diagnostics
4.7494 of 5 stars
$188.83
-0.1%
$186.00
-1.5%
+18.4%$21.12B$9.87B22.6156,000Positive News
MCK
McKesson
4.8994 of 5 stars
$762.22
+0.2%
$829.08
+8.8%
+52.6%$94.80B$359.05B30.3945,000Trending News
Analyst Revision
TMO
Thermo Fisher Scientific
4.8886 of 5 stars
$461.95
-0.5%
$588.35
+27.4%
-9.0%$174.44B$42.88B26.72125,000Positive News
Analyst Upgrade
WST
West Pharmaceutical Services
4.8844 of 5 stars
$260.04
-0.6%
$318.56
+22.5%
-9.5%$18.70B$2.89B38.9310,600Analyst Forecast

Related Companies and Tools


This page (NYSE:LH) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners